Article
Increasing Prevalence of Artemisinin-Resistant HRP2-Negative Malaria in Eritrea
27 Sept 2023
Abstract excerpt
BACKGROUND: on the continent is troubling, given the lack of alternative treatments. METHODS: that result in variable performance of histidine rich protein 2 (HRP2)-based rapid diagnostic tests for malaria. RESULTS: R622I mutation, which made them potentially undetectable by HRP2-based rapid diagnostic tests. CONCLUSIONS: in Eritrea threaten to compromise regional malaria control and elimination campaigns....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
